Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 29, 2008

View Archived Issues

Cerebral ischemia greatly increases protein sumoylation

Cypress acquires Proprius for USD 37.5 million in cash

ProMetic Life Sciences enters license agreement with Kedrion for two hyperimmunes

Soluble CD40 ligand a marker of Alzheimer's disease severity, progression

YM-202074 confers neuroprotection in a stroke model

Alimera enters agreement with Emory to develop new drugs for ophthalmic diseases

Genzyme reported Q4 2007 highlights

AstraZeneca presents update on clinical development of Recentin in NSCLC and colorectal cancer

Recent Pharmacopeia patent reports novel treatment option for autoimmune diseases

Novel agents for treating HCV infection disclosed in recent Genelabs and Gilead patents

New treatments for diabetes and related disorders described in recent patent literature

CNV reduction with picropodophyllin in experimental models

Targeting CCR3 may provide benefit in CNV associated with AMD

ISS recommends that Pharmion stockholders vote for merger agreement with Celgene

Intercell reports results from phase I clinical trial of IC-31 adjuvanted flu vaccine

7TM Pharma reports positive results from two phase I clinical studies of TM-30339 in obesity

MorphoSys and Sigma-Aldrich enter agreement for recombinant research antibodies

GSK and Theravance initiate phase IIb trial of beta-agonist GW-642444 for COPD

FDA accepts and grants priority review to Sirion's NDA for Durezol for ocular inflammation

Positive pharmacokinetic study results of once-daily ondansetron

Anadys initiates phase I ANA-773 trial in cancer patients

Athersys reports results for phase I safety study of novel obesity drug

Evotec commences phase II smoking cessation trial with EVT-302

FDA approves Arcalyst for cryopyrin-associated periodic syndromes (CAPS)

Preliminary results reported from phase III NGX-4010 trial in HIV-DSP

Japan approves Herceptin for early treatment of HER2-positive breast cancer

FDA approves Luvox CR Extended-Release capsules for SAD and OCD therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 8, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...